Radiation seeds effectively cure prostate cancer in young menOctober 30, 2007Procedure less invasive than surgery and preferred by many men Radiation seed implants (brachytherapy) are just as effective at curing prostate cancer in younger men (aged 60 and younger) as they are in older men, according to a study presented at a scientific session on October 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles. Brachytherapy is a minimally invasive procedure where a radiation oncologist places small radioactive seeds into the prostate in order to kill the cancer cells. It is an attractive treatment option for patients with prostate cancer because it has a much shorter recovery time than surgery and studies have shown brachytherapy to be just as effective as surgery. However, surgeons have usually advised younger men to undergo surgery to remove all or part of the prostate (prostatectomy) over other treatments like seed implants because they believed younger men could physically tolerate surgery, plus they believed surgery was more effective than brachytherapy at curing prostate cancer long term. This meant that many younger men would undergo surgery without ever learning about other treatment options, like brachytherapy or external beam radiation therapy.
"These results suggest that brachytherapy is extremely effective in curing localized prostate cancer for men aged 60 and younger. When younger men are diagnosed with localized prostate cancer, they should be presented with all viable treatment options, including brachytherapy," said Alice Ho, M.D., the lead author of the study and a radiation oncologist at Memorial Sloan-Kettering Cancer Center in New York. "Every man with prostate cancer, regardless of his age, should have access to the treatment that is best for his cancer and lifestyle." The large, retrospective study examined the outcomes of more than 1,700 men with localized prostate cancer who were treated with brachytherapy between 1990 and 2005 at Mount Sinai Medical Center in New York. Results show that younger men had the same excellent outcomes after undergoing brachytherapy as older patients. American Society for Therapeutic Radiology and Oncology | |||||||||||||||||||||
|
Related Brachytherapy News Articles Prostate size and other neglected factors influence prostate cancer treatment satisfaction Men with prostate cancer and their partners face difficult decisions regarding treatment, and accurate information regarding expected outcomes can be hard to find, according to results of a multi-center study published Wednesday in the New England Journal of Medicine. Patients Need To Know that Nuclear Medicine Procedures Can Trigger Radiation Alarms Twenty million nuclear medicine procedures that detect and evaluate heart disease, brain disorders and cancer-and that use radiopharmaceuticals to treat overactive thyroids and some cancers-are performed each year. 'Mismatched' prostate cancer treatment more common than expected More than a third of men with early prostate cancer who participated in a study analyzing treatment choice received therapies that might not be appropriate, based on pre-existing problems with urinary, bowel or sexual function. Jefferson radiation oncologists use real-time system to plant 'seeds' against cancer Radiation oncologists and urologists at the Kimmel Cancer Center at Jefferson and Thomas Jefferson University Hospital in Philadelphia have begun using a real-time system to implant radiation-emitting seeds in prostate cancer patients. Radiation therapy technique reduces length of prostate cancer treatment Breihan Bridgewater suffers from emphysema. He sleeps on his side because when he lays flat on his back it feels like there's a boulder resting on his chest. Prostate cancer patients see high survival rates with seed implants More than ninety percent of men who receive appropriate radiation dose levels with permanent radiation seed implants to treat their prostate cancer are cured of their cancer eight years after diagnosis. Breast cancer treatment procedure gives women more options A new minimally invasive approach to partial breast irradiation provides another treatment option for women with breast cancer. The researchers presented their findings today at the annual meeting of the Radiological Society of North America. Radiation heart dose from MammoSite compared to IMRT for left-sided breast cancers When compared to IMRT, MammoSite Brachytherapy does not always deliver lower doses of radiation to the heart during treatment of left sided breast cancers. Patients report fewer moderate and serious side effects with IMRT than with brachytherapy In one of the first studies to compare side effects of IMRT and permanent prostate brachytherapy (I-125) for treatment of low-risk prostate cancer, researchers say patients had fewer moderate and serious side effects when treated with IMRT. Combined treatment extends life expectancy for lung cancer patients Combining thermal ablation with radiation therapy extends average life expectancy and decreases recurrences of tumors in patients who have early stages of inoperable lung cancer, according to researchers at Rhode Island Hospital. More Brachytherapy News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||